Sara Sofia De Lucia

Università Cattolica del Sacro Cuore

Papers

1

Total Citations

49

H-Index

1

About

Sara Sofia De Lucia is a leading voice in the fight against pancreatic cancer, a disease she describes as a persistent "social and medical burden" despite modern medical advances. Her research is laser-focused on the intersection of oncology, precision medicine, and early detection, aiming to dismantle the high mortality rates associated with this notoriously difficult-to-diagnose cancer. Her most-cited work, the 2023 "State-of-the-Art and Upcoming Innovations in Pancreatic Cancer Care," has already garnered 49 citations, establishing her as a key synthesizer of emerging therapeutic strategies. In this influential review, De Lucia not only maps the current landscape of treatment but also charts a bold course toward personalized care, emphasizing the critical need for innovative biomarkers and targeted therapies. Her contributions are pivotal in shifting the paradigm from reactive treatment to proactive, precision-based intervention. For students and researchers, De Lucia’s work represents a beacon of hope in a field where early diagnosis remains elusive, and her clear-eyed analysis of upcoming innovations provides a vital roadmap for the next generation of cancer researchers.

Research Focus

Key Achievements

1
H-Index
1
Papers
49
Total Citations
49
Avg Citations/Paper
🏆 Most Cited Paper
State-of-the-Art and Upcoming Innovations in Pancreatic Cancer Care: A Step Forward to Precision Medicine
49 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Università Cattolica del Sacro Cuore

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago